Baird Medical Investment HolBDMD
13F holders, Q1 2026 (March 31)8holders
2new positions
2sold out
$1.91avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding Baird Medical Investment Hol (BDMD) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Highbridge Capital Management LLC ($230K), UBS Group AG ($133K) and Two Sigma Investments, LP ($91K).
- Company
- Baird Medical Investment Hol
- CUSIP
- G0705H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $116K |
| Exits | 2 | $267K |
All 13F filers, Q4 2025 → Q1 2026: 93,373 shares bought and 286,516 shares sold, net −193,143 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Highbridge Capital Management LLC | 0.02% | No change | 125,000 | $230K |
| UBS Group AG | 0.00% | Add +100.2% | 67,863 | $133K |
| Two Sigma Investments, LP | 0.00% | Reduce -51.2% | 46,587 | $91K |
| Jane Street Group, LLC | 0.00% | New | 39,416 | $77K |
| Geode Capital Management, LLC | 0.00% | No change | 25,442 | $50K |
| Morgan Stanley | 0.00% | New | 20,000 | $39K |
| National Bank of Canada | 0.00% | No change | 11,700 | $22K |
| Wolverine Asset Management LLC | 0.00% | No change | 205 | $402 |
"% of holder's portfolio" is BDMD's weight in each manager's 13F, not the share of Baird Medical Investment Hol the manager owns.